You are here:

Archived: bemiparin 3500 IU in 0.2ml injection for sub-cutaneous administration (Zibor)

Advice

Following a resubmission

bemiparin (Zibor) is not recommended for use within NHS Scotland for the prevention of thromboembolic events in patients undergoing orthopaedic surgery.

Bemiparin was associated with a lower incidence of thromboembolic complications than unfractionated heparin and was non-inferior to another low molecular weight heparin.

The manufacturer did not present a sufficiently robust economic analysis to gain acceptance by SMC.

Drug Details

Drug Name: bemiparin 3500 IU in 0.2ml injection for sub-cutaneous administration (Zibor)
SMC Drug ID: 204/05
Manufacturer: Pan Quimica Farmaceutica S.A.
Indication: Prevention of thromboembolic disease in patient undergoing orthopaedic surgery
BNF Category:
Sub Category: 2.8 Anticoagulants and protamine
Submission Type: Resubmission
Status: Not Recommended
Date Advice Published: 9 July 2007

Current Advice

Resubmission 7 December 2009

Archived Advice

Full submission 10 October 2005

Back